HomeNewsBusinessStartupCoronavirus pandemic | It's Startup Vs Covid-19 as techies, investors help states fight outbreak

Coronavirus pandemic | It's Startup Vs Covid-19 as techies, investors help states fight outbreak

The 900-member strong body is pooling technology and resources to lend a hand to state governments in these trying times.

April 02, 2020 / 09:57 IST
Story continues below Advertisement
Representative Image
Representative Image

With coronavirus cases rising steadily across the country, Indian startups are banding together to lend a hand to state governments in what is increasingly looking like a tough fight.

Entrepreneurs, investors and tech professionals have come together on social media platforms as Startup Vs Covid-19, a collective to support the states and each other, pooling technology as well as resources.

Story continues below Advertisement

“We started with our telemedicine helpline which is operational, it is supplementing the 104 government helplines for all queries around COVID-19,” said Mekin Maheshwari, a prominent angel investor and the founder of Udhyam.org.

COVID-19 is the respiratory illness caused by the novel coronavirus. India has, so far, reported 1,637 infections and 38 deaths.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show